Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 439

1.

Genetic variants in CYP and GST genes, smoking and risk for head and neck cancers: a gene-environment interaction hospital-based case-control study among Canadian Caucasians.

ThekkePurakkal AS, Nicolau B, Burk RD, Franco EL, Schlecht NF.

Carcinogenesis. 2019 Apr 2. pii: bgz051. doi: 10.1093/carcin/bgz051. [Epub ahead of print]

PMID:
30938417
2.

Restoring Dignity in Academic Publishing Is a Collective Duty.

Shapiro SB, Franco EL.

JDR Clin Trans Res. 2019 Jan;4(1):5-8. doi: 10.1177/2380084418806839. Epub 2018 Oct 8. No abstract available.

PMID:
30931756
3.

Lack of association between human papillomavirus types 6 and 11 genetic variants and cervical abnormalities: The Ludwig-McGill cohort study.

Sichero L, El-Zein M, Ferreira S, Franco EL, Villa LL.

Cancer Epidemiol Biomarkers Prev. 2019 Mar 13. pii: cebp.0114.2019. doi: 10.1158/1055-9965.EPI-19-0114. [Epub ahead of print]

PMID:
30867221
4.

Improving the reporting of cancer-specific mortality and survival in research using cancer registry data.

Wissing MD, Greenwald ZR, Franco EL.

Cancer Epidemiol. 2019 Apr;59:232-235. doi: 10.1016/j.canep.2019.02.004. Epub 2019 Mar 2.

PMID:
30836221
5.

The future burden of cancer in Canada: Long-term cancer incidence projections 2013-2042.

Poirier AE, Ruan Y, Walter SD, Franco EL, Villeneuve PJ, King WD, Volesky KD, O'Sullivan DE, Friedenreich CM, Brenner DR; ComPARe Study Team.

Cancer Epidemiol. 2019 Apr;59:199-207. doi: 10.1016/j.canep.2019.02.011. Epub 2019 Mar 1.

6.

Persistence of human papillomavirus 16, 18 and 52 variants in Inuit women from Northern Quebec, Canada.

Gauthier B, Cerigo H, Coutlée F, Franco EL, Brassard P.

Int J Circumpolar Health. 2018 Dec;77(1):1556556. doi: 10.1080/22423982.2018.1556556.

PMID:
30827197
7.

Hand-to-genital and genital-to-genital transmission of human papillomaviruses between male and female sexual partners (HITCH): a prospective cohort study.

Malagón T, Louvanto K, Wissing M, Burchell AN, Tellier PP, El-Zein M, Coutlée F, Franco EL.

Lancet Infect Dis. 2019 Mar;19(3):317-326. doi: 10.1016/S1473-3099(18)30655-8. Epub 2019 Feb 10.

PMID:
30745276
8.

Limitations of simulation models for cervical cancer screening - Authors' reply.

Malagón T, Kulasingam S, Franco EL.

Lancet Oncol. 2019 Feb;20(2):e69. doi: 10.1016/S1470-2045(19)30012-9. No abstract available.

PMID:
30712802
9.

Use of HPV testing in cervical cancer screening services in Mexico, 2008-2018: a nationwide database study.

Hurtado-Salgado E, Ortiz-Panozo E, Salmerón J, Saavedra-Lara N, Kuri-Morales P, Pesqueira-Villegas E, Luna-Gordillo R, Franco EL, Lazcano-Ponce E.

Salud Publica Mex. 2018 Nov-Dic;60(6):722-733. doi: 10.21149/9891.

PMID:
30699277
10.

Prevention of cervical cancer in Latin America: Future challenges and opportunities.

Franco EL.

Salud Publica Mex. 2018 Nov-Dic;60(6):609-611. doi: 10.21149/10071. No abstract available.

PMID:
30699263
11.

Human Papillomavirus Vaccine Effectiveness and Herd Protection in Young Women.

Spinner C, Ding L, Bernstein DI, Brown DR, Franco EL, Covert C, Kahn JA.

Pediatrics. 2019 Feb;143(2). pii: e20181902. doi: 10.1542/peds.2018-1902. Epub 2019 Jan 22.

PMID:
30670582
12.

Human Papillomavirus Infection and Transmission Among Couples Through Heterosexual Activity (HITCH) Cohort Study: Protocol Describing Design, Methods, and Research Goals.

El-Zein M, Coutlée F, Tellier PP, Roger M, Franco EL, Burchell AN; HITCH Study Group.

JMIR Res Protoc. 2019 Jan 16;8(1):e11284. doi: 10.2196/11284.

13.

Evidence for cross-protection but not type-replacement over the 11 years after human papillomavirus vaccine introduction.

Covert C, Ding L, Brown D, Franco EL, Bernstein DI, Kahn JA.

Hum Vaccin Immunother. 2019 Jan 11:1-8. doi: 10.1080/21645515.2018.1564438. [Epub ahead of print]

PMID:
30633598
14.

Increased risk of oropharyngeal cancers mediated by oral human papillomavirus infection: Results from a Canadian study.

Laprise C, Madathil SA, Schlecht NF, Castonguay G, Soulières D, Nguyen-Tan PF, Allison P, Coutlée F, Hier M, Rousseau MC, Franco EL, Nicolau B.

Head Neck. 2019 Mar;41(3):678-685. doi: 10.1002/hed.25436. Epub 2019 Jan 3.

PMID:
30605251
15.

Assessing the time dependence of prognostic values of cytology and human papillomavirus testing in cervical cancer screening.

Isidean SD, Wang Y, Mayrand MH, Ratnam S, Coutlée F, Franco EL, Abrahamowicz M; CCCaST Study Group.

Int J Cancer. 2019 May 15;144(10):2408-2418. doi: 10.1002/ijc.31970. Epub 2019 Jan 21.

PMID:
30411802
16.

Age at last screening and remaining lifetime risk of cervical cancer in older, unvaccinated, HPV-negative women: a modelling study.

Malagón T, Kulasingam S, Mayrand MH, Ogilvie G, Smith L, Bouchard C, Gotlieb W, Franco EL.

Lancet Oncol. 2018 Dec;19(12):1569-1578. doi: 10.1016/S1470-2045(18)30536-9. Epub 2018 Nov 1. Erratum in: Lancet Oncol. 2019 Jan;20(1):e10.

PMID:
30392810
17.

Comparative performance of human papillomavirus messenger RNA versus DNA screening tests at baseline and 48 months in the HPV FOCAL trial.

Cook DA, Smith LW, Law JH, Mei W, Gondara L, van Niekerk DJ, Ceballos KM, Jang D, Chernesky M, Franco EL, Ogilvie GS, Coldman AJ, Krajden M.

J Clin Virol. 2018 Nov;108:32-37. doi: 10.1016/j.jcv.2018.09.004. Epub 2018 Sep 10.

PMID:
30223252
18.

HLA and KIR Associations of Cervical Neoplasia.

Bao X, Hanson AL, Madeleine MM, Wang SS, Schwartz SM, Newell F, Pettersson-Kymmer U, Hemminki K, Tiews S, Steinberg W, Rader JS, Castro F, Safaeian M, Franco EL, Coutlée F, Ohlsson C, Cortes A, Marshall M, Mukhopadhyay P, Cremin K, Johnson LG, Garland SM, Tabrizi SN, Wentzensen N, Sitas F, Trimble C, Little J, Cruickshank M, Frazer IH, Hildesheim A, Brown MA, Duncan EL, Sun YP, Leo PJ.

J Infect Dis. 2018 Nov 5;218(12):2006-2015. doi: 10.1093/infdis/jiy483.

PMID:
30099516
19.

Estimating the current and future cancer burden in Canada: methodological framework of the Canadian population attributable risk of cancer (ComPARe) study.

Brenner DR, Poirier AE, Walter SD, King WD, Franco EL, Demers PA, Villeneuve PJ, Ruan Y, Khandwala F, Grevers X, Nuttall R, Smith L, De P, Volesky K, O'Sullivan D, Hystad P, Friedenreich CM; ComPARe Study Group.

BMJ Open. 2018 Aug 1;8(7):e022378. doi: 10.1136/bmjopen-2018-022378.

20.

Epidemiology of Any and Vaccine-Type Anogenital Human Papillomavirus Among 13-26-Year-Old Young Men After HPV Vaccine Introduction.

Chandler E, Ding L, Gorbach P, Franco EL, Brown DA, Widdice LE, Bernstein DI, Kahn JA.

J Adolesc Health. 2018 Jul;63(1):43-49. doi: 10.1016/j.jadohealth.2018.01.005.

PMID:
30060856

Supplemental Content

Loading ...
Support Center